Ep 229 - Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?

Ep 229 - Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?
DeviceTalks Weekly
Ep 229 - Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?

Mar 07 2025 | 00:53:04

/
Episode 229 • March 07, 2025 • 00:53:04

Hosted By

Tom Salemi

Show Notes

In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers. But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies. You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/ Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Previous Episode

Ep 228 - Hear Part 1 of Lungpacer Medical’s AeroPace Story; Be part of the conclusion at DeviceTalks Boston

Next Episode

Ep 230 - BIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical Robotics

Other Episodes

July 21, 2023

Ep 156 - Elixir Medical CEO explains how new scaffold system could move vascular treatment beyond the stent

In this episode, Host Tom Salemi learns the Elixir Medical story from CEO Motasim Sirhan, who has spent most of his medtech career developing...

Play

00:48:42

April 02, 2021

Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic....

Play

01:04:33

April 22, 2022

Ep 100 - Hear how Shockwave and LimFlow are taking the fight to peripheral vascular diseases

In this episode, we’ll talk to two of the more innovative companies in the peripheral vascular space – Shockwave Medical and LimFlow – about...

Play

01:49:18